Saffer has been chief technology officer of the company since its spinoff from Battelle in 2000, and will continue in this role.
Prior to joining the Maynard,
Pierre Cassigneul, a veteran of the diagnostics industry, has been appointed operating partner of biopharma and bio-IT consulting firm
Cassigneul comes to the firm from Becton Dickinson, where he was vice president of diabetes management.
Previously, he was senior vice president of Bayer, and general manager of the company's diabetes self-testing arm. He has also served in leadership roles of Ortho Diagnostic Systems' AIDS and hepatitis business unit, and Abbott Laboratories; and held a market research position at Eurequip in
Todd Edwards has been appointed field technical specialist at Protedyne, the lab automation equipment provider said Tuesday.
Edwards will cover the western US, and will work with customers to implement the company's Protocol for Automation, a way to define a company's automation needs and how to meet them.
Edwards comes to Protedyne from Lawrence Livermore National Laboratory, where he was a post-doctoral researcher in Joanna Albala's lab, developing automated techniques for protein expression and purification. He has also worked as an assistant professor at
David McGee, a co-founder of Large Scale Biology and executive vice president, is leaving the company, LSBC said June 13 in announcing a restructuring.
McGee will "pursue consulting in the biotechnology field," the company said.
Willem 'Pim' Stemmer has joined the scientific advisory board of Nuevolution, the
Stemmer co-founded Avidia, a company that performs directed evolution of antibody-like products, earlier this year. He also founded Maxygen in 1997, to market his molecular breeding DNA recombination and functional selection technology to life sciences and agriculture. These companies stem from Stemmer's invention in 1993 of DNA shuffling technology, when he was a scientist at Affymax Research Institute. Stemmer previously worked as a research scientist at Hybritech, and in 1985 founded Genetic Designs, which performed phage display, codon-based synthesis and E. coli antibody expression.
Michael Raymont has been appointed vice president of technology and industry support for
Additionally, Peter Hackett, the NRC's vice president of research and technology development, has now been put in charge of its life sciences and information technology arm.
These appointments come as the NRC reorganizes. The technology and industry support portfolio that Raymont oversees now includes under its umbrella the NRC's Research Assistance Program (NRC-IRAP), which is designed to help small- and medium-sized research companies in
Additionally, Hacket will oversee the NRC's five biotechnology institutes, including theBiotechnology Research Institute (NRC-BRI), the NRC Institute for Biological Sciences (NRC-IBS), the NRC Plant Biotechnology Institute (NRC-PBI), the NRC Institute for Biodiagnostics (NRC-IBD), the NRC Institute for Marine Biosciences (NRC-IMB) and the associated genomics and health initiative. Hackett also oversees the NRC Steacie Institute for Molecular Sciences (NRC-SIMS), the NRC National Institute for Nanotechnology (NINT), the NRC Institute for National Measurement Standards (NRC-INMS), the NRC Institute for Microstructural Sciences (NRC-IMS) and the NRC Institute for Information Technology (NRC-IIT).